Pfizer, Moderna and Janssen vaccine InflammoThrombotic and Prion Type Effect on Erythrocytes When Added to Human Blood

Background: Three EUA approved drug vaccine biologics have been approved for use by the United States Food and Drug Administration (FDA) for SARS-CoV-2. Their effect upon erythrocytes has not previously been reported. Methods: Seven individuals (4 men; 3 women) including two people with prior SARS-CoV-2 infections, one previously vaccinated with the Pfizer vaccine (two doses), and one previously vaccinated with the Moderna vaccine (three doses including one booster) provided blood drawn by venipuncture for analysis. In the first part of the study, one male subjected provided blood by venipuncture analysis. This blood was microscopically analyzed before and after the administration of the Pfizer BioNTech vaccine and normal saline. In the second part of the study, 3 men and 3 women provided blood samples obtained by venipuncture. Each of the individual's blood was directly examined microscopically before and after administration of the Pfizer, Moderna, and Janssen vaccines to the blood. In the third part of the study the vaccines were independently analyzed for extraneous material. Results: Seven individuals including 4 men and 3 women showed normal erythrocyte coloration when their blood was drawn by venipuncture. Each individual's blood when analyzed microscopically demonstrated normal morphology and appearance. In each instance, the administration of the Pfizer, Moderna, or Janssen vaccines directly into the blood on peripheral blood smear demonstrated an almost immediate loss of red color. This loss of red color persisted throughout the examination and was only seen where the vaccines mixed with erythrocytes. As the vaccines spread across the blood smear, the erythrocytes demonstrated (a) a loss of red color that was not transient, (b) clumping of erythrocytes not observed during the same time period following the administration of normal saline to the blood, and (c) alterations in the morphology of erythrocytes. While several of the vials had extraneous material; none of them had evidence of significant graphene oxide, living organisms, or nanotechnology. Conclusion: Administration of Pfizer, Moderna, and Janssen vaccines resulted in the immediate loss of red coloration present in erythrocytes. This loss of red coloration indicates that there is a disruption of the hemoglobin binding of oxygen. Since atmospheric oxygen is immediately available to re-saturate the hemoglobin molecules restoring the red color responsible for the function and name of erythrocytes; the results of this investigation suggest that there is an alteration in the hemoglobin molecule preventing the hemoglobin from binding with oxygen. This alteration of the hemoglobin molecule could be explained if the vaccines merge with the erythrocytes and release their genetic material (RNA or DNA) directly into the erythrocytes; having a prion altering effect upon the hemoglobin molecule. Some of the vaccine samples included extraneous materials. The vaccines did not include observable graphene oxide, eggs or living organisms.